Drug · CHEMBL15768

CAMPHOR

7 sourcespipelines-2026-09-18-0.3.1

Cite this record

ConductScience Library. CAMPHOR. Drugs and targets, record CHEMBL15768. Release pipelines-2026-09-18-0.3.1, 18 Sept 2026. https://conductscience.org/library/drugs/CHEMBL15768

On this page

Drug

Names and IDs as ChEMBL gives them, through Open Targets.

Name: CAMPHOR; ChEMBL
ChEMBL ID: CHEMBL15768; ChEMBL
Type: Small molecule; ChEMBL
Other names: Camphor (natural), Camphor (synthetic), Camphor d-form, Camphor laurel, Camphor laurel whole, Camphor tree whole, Camphor whole, Camphor, d-, Camphor, dl-, Camphor, racemic, Camphora, Camphora camphora, Camphora officinalis whole, Camphora tree, Camphortree whole, Camphorwood, Cinnamomum camphora, Cinnamomum camphora whole, Cinnamonum camphora, D-camphor, Dextrocamphor, Dl-camphor, FEMA NO. 2230, FEMA NO. 4513, Gum camphor, Karpura whole, Laurus camphora, NSC-755918, Natural camphor, Synthetic camphor, Trans-pi-oxocamphor; ChEMBL
DrugBank: DB14156; DrugBank
InChIKey: DSSYKIVIOFKYAU-UHFFFAOYSA-N; ChEMBL
Open Targets' highest stage: Approval, for 13 of its 13 diseases, from ATC and DailyMed; Open Targets

Targets0

The targets ChEMBL's mechanism records give for the drug, through Open Targets. A mechanism record says what the drug acts on, not how strongly.

None in this release.

Diseases13

The diseases Open Targets' clinical reports study the drug for, the most trial reports first. The stage is Open Targets', the highest any of its sources reports for the pair, and each row names the sources that report it.

Disease	Open Targets' stage	Stage reported by	Reports	Of them trials	Its drugs
Cough	Approval	DailyMed	19	1	https://conductscience.org/library/drugs?q=HP_0012735
common cold	Approval	DailyMed	14	0	https://conductscience.org/library/drugs?q=MONDO_0005709
Pain	Approval	DailyMed	10	0	https://conductscience.org/library/drugs?q=HP_0012531
Back pain	Approval	DailyMed	7	0	https://conductscience.org/library/drugs?q=HP_0003418
Nasal congestion	Approval	DailyMed	7	0	https://conductscience.org/library/drugs?q=HP_0001742
arthritic joint disease	Approval	DailyMed	7	0	https://conductscience.org/library/drugs?q=MONDO_0005578
sprain	Approval	DailyMed	7	0	https://conductscience.org/library/drugs?q=EFO_0009582
Pruritus	Approval	DailyMed	3	0	https://conductscience.org/library/drugs?q=HP_0000989
herpes labialis	Approval	DailyMed	3	0	https://conductscience.org/library/drugs?q=MONDO_0043653
cardiovascular disorder	Approval	ATC	1	0	https://conductscience.org/library/drugs?q=MONDO_0004995

1 to 10 of 13Source Open Targets

See all 13 diseases

Trials4

Trials whose record names the drug by a name ChEMBL states, posted results first, then the largest. Open Targets read each trial's text to find its drugs.

Trial	Title	Phase	Participants	Named as	Linked by	Source
NCT01119534	Comparative Efficacy of the Suppository Versus Guaiacol Suppository Versus Guaifenesin Syrup in Pediatric Patients With Cough Due the Infectious Origin	Phase 3	270	camphor	Its name	ClinicalTrials.gov
NCT02581397	Transpulmin Suppository and Guaiacol Compared to Transpulmin Syrup in Pediatric Participants With Productive Cough	Phase 3	270	camphor	Its name	ClinicalTrials.gov
NCT05411913	Topical CBD for Musculoskeletal Pain	Phase 3	100	camphor	Its name	ClinicalTrials.gov
NCT00299559	Kinetics of Etheric Oils, Smart Textiles vs. Ointment	Phase 1	6	camphor	Its name	ClinicalTrials.gov

Comparisons in its trials0

Comparisons Trial comparisons calculated in the trials whose record names the drug, most participants first. A comparison in one of its trials does not always compare the drug, so read the two groups.

None in this release.

Papers from its trials0

The papers the trials whose record names the drug list on ClinicalTrials.gov as their results (RESULT) or as drawn from them (DERIVED), results first, newest first.

None in this release.

Tests in its trials0

The tests ConductCognition runs that the trials whose record names the drug name in their registered outcomes, as ScienceGraph matched them. ConductCognition's list names the tests it runs, not every test a trial used.

None in this release.

Data dates

The date of each source this release read.

Open Targets: 2026-09-18; Open Targets
ClinicalTrials.gov: 2026-11-05; ClinicalTrials.gov
Results, from AACT: 2026-03-23; AACT
Papers the trials list, from Trials: 2026-11-12; Trials
Comparisons, from Trial comparisons: 2026-03-23; Trial comparisons
Tests named in the trials, as ScienceGraph matched them: 2026-11-12; ConductCognition

Sources 7

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ChEMBL, through Open TargetsCC BY-SA 3.0
ConductCognition's list of its testsOur own data
ClinicalTrials.govNo license stated
NLM's MeSHNLM's terms
Open TargetsCC0 1.0
PubMedNLM's terms

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ConductCognition's list of its testsOur own data: ConductCognition's list of its tests, https://conductcognition.com
ClinicalTrials.govnone stated
NLM's MeSHNLM's
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PubMedNLM's terms

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this drug from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/drugs/v1/CHEMBL15768

GET https://conductscience.org/api/drugs/v1/CHEMBL15768/targets

API reference For AI assistants